In addition, both IDH mutant glioma cells and astrocytes were resistant to NK cell‐mediated lysis, whereas decitabine increased NKG2D ligand expression and restored NK‐mediated lysis in IDH mutant cells in an NKG2D‐dependent manner. Here, KLRK1 is linked to central nervous system cancer.